With an aging population, kidney health becomes an important medical and socioeconomic factor. Kidney aging…
dcorriganSeptember 7, 2022
Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating…
dcorriganSeptember 6, 2022
BBI’s Dr. Albert Folch has three passions in life: microfluidics, art, and soccer. It might…
dcorriganSeptember 2, 2022
Humoral immunity to SARS-CoV-2 can be supplemented with polyclonal sera from convalescent donors or an…
dcorriganSeptember 2, 2022
Vilya, Inc. broke onto the BioForest biotech scene Monday with $50 million in Series A proceeds. The company will…
dcorriganSeptember 2, 2022
Dr. Daphne Avgousti studies viruses and the ways that they hijack fundamental structures in our…
dcorriganSeptember 1, 2022
Sonoma Biotherapeutics, a richly funded startup developing cell therapies for autoimmune and inflammatory diseases, is…
dcorriganSeptember 1, 2022
Today, the White House Office of Science and Technology Policy (OSTP) updated U.S. policy guidance…
dcorriganAugust 31, 2022
